Delivery Order SPE2DB24D2003-SPE2DB25FXJM0
Award Date
6/10/25
Potential Completion Date
6/11/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,449.50 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine product. The delivery order has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This is a $18,827.91 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a period of performance through February 11, 2025. The contract is an open competition award with no set-aside designation. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This is a $122,896.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, to support military and federal healthcare programs. The contract has an ultimate completion date of July 16, 2024 and was awarded on July 15, 2024. No set-aside designation was used for this open...
This is a $9,156.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a medical vaccine product. The award is part of Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This is a $39,598.42 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The order is for the supply of 4,565,235,791 units of the TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccine. The contract has a period of performance through July 25, 2024 and was awarded on July 24, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a $4,316.45 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a period of performance through March 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This is a $46,466.50 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product, with a completion date of February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a $31,941.73 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines, with a period of performance through May 21, 2025. The contract is not set-aside and allows for the supply of pharmaceutical products and medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp also holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,949.35 firm-fixed-price contract is for the delivery of 4566975119 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML vaccines. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,540.09 firm fixed-price delivery order is for the supply of 4567474665 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has a period of performance through March 6, 2025 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...